Charles River Laboratories International (CRL) Other Non Operating Income (2009 - 2025)
Charles River Laboratories International (CRL) posted quarterly Other Non Operating Income of $12.1 million for Q4 2025, up 153.29% year-over-year from $4.8 million in Q4 2024, and up 153.49% on a QoQ basis from -$22.6 million in Q3 2025.
Charles River Laboratories International (CRL) Other Non Operating Income (2009 - 2025) Analysis & Trends
Charles River Laboratories International (CRL) has reported Other Non Operating Income for 17 consecutive years, with $12.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Non Operating Income rose 153.29% year-over-year to $12.1 million; the TTM figure through Dec 2025 stood at -$22.6 million (down 36.66% YoY), while the FY2025 annual figure was -$22.6 million, down 36.66% from the prior year.
- Other Non Operating Income came in at $12.1 million for Q4 2025 at Charles River Laboratories International, up from -$22.6 million in the prior quarter.
- The five-year high for Other Non Operating Income was $115.5 million in Q4 2022, with the low at -$39.8 million in Q2 2022.
- Average Other Non Operating Income over 5 years is $2.6 million, with a median of -$3.0 million recorded in 2023.
- Across the five-year window, Other Non Operating Income jumped 5476.59% in 2022 and plunged 972.61% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $2.1 million in 2021, then surged by 5476.59% to $115.5 million in 2022, then fell by 6.76% to $107.7 million in 2023, then tumbled by 121.07% to -$22.7 million in 2024, then soared by 153.29% to $12.1 million in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $12.1 million, -$22.6 million, and $154000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Charles River Laboratories International | 11.36 Bn | 11.15 Bn | 744.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 12.10 Mn |
| Sep 27, 2025 | -22.62 Mn |
| Jun 28, 2025 | 154,000.00 |
| Mar 29, 2025 | -12.21 Mn |
| Dec 28, 2024 | -22.71 Mn |
| Sep 28, 2024 | 2.59 Mn |
| Jun 29, 2024 | -2.24 Mn |
| Mar 30, 2024 | 5.83 Mn |
| Dec 30, 2023 | 107.74 Mn |
| Sep 30, 2023 | -6.26 Mn |
| Jul 1, 2023 | -2.66 Mn |
| Apr 1, 2023 | -3.28 Mn |
| Dec 31, 2022 | 115.55 Mn |
| Sep 24, 2022 | -16.62 Mn |
| Jun 25, 2022 | -39.78 Mn |
| Mar 26, 2022 | -28.63 Mn |
| Dec 25, 2021 | 2.07 Mn |
| Sep 25, 2021 | -16.21 Mn |
| Jun 26, 2021 | 5.97 Mn |
| Mar 27, 2021 | -27.72 Mn |